Total Payments
$3,322
2024 Payments
$1,198
Companies
18
Transactions
154
Medicare Patients
1,770
Medicare Billing
$122,304
Payment Breakdown by Category
Food & Beverage$3,316 (99.8%)
Education$6.61 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,316 | 153 | 99.8% |
| Education | $6.61 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $938.56 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $328.15 | 3 | $0 (2023) |
| Celgene Corporation | $284.73 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $267.72 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $248.28 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $244.95 | 14 | $0 (2024) |
| Ardelyx, Inc. | $201.22 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $182.18 | 9 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $139.29 | 6 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $112.91 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,198 | 62 | ABBVIE INC. ($220.01) |
| 2023 | $1,543 | 62 | ABBVIE INC. ($462.50) |
| 2022 | $581.17 | 30 | ABBVIE INC. ($256.05) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.13 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 08/26/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $27.93 | General |
| Category: GI | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.92 | General |
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.24 | General |
| 08/13/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: Neuroscience | ||||||
| 07/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.01 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 07/09/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.19 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 384 | 447 | $87,322 | $25,751 |
| 2022 | 3 | 438 | 461 | $94,830 | $25,989 |
| 2021 | 5 | 512 | 569 | $131,325 | $46,267 |
| 2020 | 5 | 436 | 483 | $85,466 | $24,297 |
Total Patients
1,770
Total Services
1,960
Medicare Billing
$122,304
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 275 | 335 | $65,718 | $19,190 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 53 | 53 | $13,462 | $4,388 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 56 | 59 | $8,142 | $2,173 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 202 | 224 | $43,904 | $14,063 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 144 | $31,536 | $6,633 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 35 | 35 | $8,890 | $2,942 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 30 | 31 | $4,278 | $1,310 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $2,250 | $561.48 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,972 | $478.10 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 295 | 344 | $75,672 | $28,517 | 37.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 106 | 106 | $35,086 | $11,142 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 86 | $12,900 | $3,539 | 27.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 19 | $5,567 | $2,369 | 42.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 14 | $2,100 | $699.41 | 33.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 210 | 257 | $38,550 | $10,334 | 26.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 79 | 79 | $26,149 | $7,101 | 27.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 51 | $11,169 | $3,593 | 32.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 63 | 63 | $4,648 | $1,662 | 35.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 33 | $4,950 | $1,607 | 32.5% |
About Heather Camp, FNP
Heather Camp, FNP is a Family healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1902184567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Camp, FNP has received a total of $3,322 in payments from pharmaceutical and medical device companies, with $1,198 received in 2024. These payments were reported across 154 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,316).
As a Medicare-enrolled provider, Camp has provided services to 1,770 Medicare beneficiaries, totaling 1,960 services with total Medicare billing of $122,304. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Gastroenterology
- Location Charlottesville, VA
- Active Since 08/01/2011
- Last Updated 11/22/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1902184567
Products in Payments
- ZEPOSIA (Drug) $612.88
- SKYRIZI (Biological) $284.11
- RINVOQ (Biological) $269.58
- ENTYVIO (Biological) $244.95
- IBSRELA (Drug) $201.22
- XIFAXAN (Drug) $184.22
- DUPIXENT (Biological) $151.36
- Linzess (Drug) $139.29
- LINZESS (Drug) $134.89
- OCALIVA (Drug) $112.91
- CREON (Drug) $109.42
- SUCRAID (Drug) $105.00
- MAVYRET (Drug) $81.02
- REMICADE (Biological) $69.94
- TRULANCE (Drug) $64.06
- STELARA (Biological) $62.45
- VIBERZI (Drug) $59.54
- TREMFYA (Drug) $49.79
- ZENPEP (Drug) $49.14
- VELSIPITY (Drug) $26.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Charlottesville
Ellen Wermter, Np, NP
Family — Payments: $209,331
Family $209,331
Amy Beyer, Fnp-C, FNP-C
Family — Payments: $5,859
Family $5,859
Adam Navone
Family — Payments: $2,330
Family $2,330
Dr. Rachel Talbot, Dnp, DNP
Family — Payments: $1,769
Family $1,769
Jessica Denomme, Fnp, FNP
Family — Payments: $1,444
Family $1,444
Mrs. Lorraine Rilko, Fnp, FNP
Family — Payments: $1,383
Family $1,383